Clinical chemistry and laboratory medicine · 2025
Robustness of steroidomics-based machine learning for diagnosis of primary aldosteronism: a laboratory medicine perspective.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eisenhofer Graeme, Peitzsch Mirko, Mantik Kevin, Schulze Manuel, Constantinescu Georgiana, Lu Zhong, Remde Hanna, Fuss Carmina T, Williams Tracy Ann, Gruber Sven, Lenders Jacques W M, Horvath Andrea, Pamporaki Christina
Аннотация
OBJECTIVES: Use of machine learning (ML) in diagnostics offers promise to optimise interpretation of laboratory data and guide clinical decision-making. For this, ML-based outputs should provide robustly reproducible results at least as good as the underlying laboratory data. The objective of this study was to assess robustness of ML-based steroid-probability-scores for diagnosis of primary aldosteronism (PA).
METHODS: Reproducibility of ML-based steroid-probability-scores was assessed from coefficients of variation (CVs) for pools of quality control plasma from selected groups of patients with and without PA. Intra-patient measurement variability was assessed from CVs of three consecutive plasma specimens obtained on different days from 77 patients. Inter-laboratory reproducibility was assessed from 47 duplicate plasma specimens analysed in two different laboratories.
RESULTS: Support vector machine-derived steroid-probability-scores for diagnosis of PA for seven sets of quality control plasma pools yielded an averaged CV (2.5 % CI 0.4-4.4 %) that was lower (p=0.0078) than the averaged CV for seven steroids employed in that model (12.0 % CI 7.4-16.6). Using three sets of plasma samples from 77 patients, CVs for intra-patient measurement variability of steroid-probability-scores were 7 % (CI 5-9 %) and lower (p<0.0001) than CVs for measurements of aldosterone (38 % CI 32-42 %), 18-oxocortisol (36 % CI 29-43 %), 18-hydroxycortisol (25 % CI 21-28 %) and the aldosterone:renin ratio (46 % CI 38-55 %). ML-derived probability scores for 47 duplicate plasma samples analysed at two separate laboratories displayed excellent agreement and negligible bias.
CONCLUSIONS: ML-based steroid-probability-scores for diagnosis of PA display remarkably high robustness according to reproducibility of measurements within and between laboratories as well as within patients.
METHODS: Reproducibility of ML-based steroid-probability-scores was assessed from coefficients of variation (CVs) for pools of quality control plasma from selected groups of patients with and without PA. Intra-patient measurement variability was assessed from CVs of three consecutive plasma specimens obtained on different days from 77 patients. Inter-laboratory reproducibility was assessed from 47 duplicate plasma specimens analysed in two different laboratories.
RESULTS: Support vector machine-derived steroid-probability-scores for diagnosis of PA for seven sets of quality control plasma pools yielded an averaged CV (2.5 % CI 0.4-4.4 %) that was lower (p=0.0078) than the averaged CV for seven steroids employed in that model (12.0 % CI 7.4-16.6). Using three sets of plasma samples from 77 patients, CVs for intra-patient measurement variability of steroid-probability-scores were 7 % (CI 5-9 %) and lower (p<0.0001) than CVs for measurements of aldosterone (38 % CI 32-42 %), 18-oxocortisol (36 % CI 29-43 %), 18-hydroxycortisol (25 % CI 21-28 %) and the aldosterone:renin ratio (46 % CI 38-55 %). ML-derived probability scores for 47 duplicate plasma samples analysed at two separate laboratories displayed excellent agreement and negligible bias.
CONCLUSIONS: ML-based steroid-probability-scores for diagnosis of PA display remarkably high robustness according to reproducibility of measurements within and between laboratories as well as within patients.